T1	Participants 103 117	acne vulgaris:
T2	Participants 242 264	moderate acne vulgaris
T3	Participants 280 351	(240 patients) in both intention-to-treat and per-protocol populations.
T4	Participants 1088 1110	moderate acne vulgaris
